ALX ONCOLOGY HOLDINGS INC (ALXO) › Capital ExpendituresALX ONCOLOGY HOLDINGS INC (ALXO) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2018: $653.0K2019: $353.0K2020: $31.0K2021: $666.0K2022: $1.43M2023: $1.27M2024: $447.0K2025: $212.0K$212.0K2018Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$212.0K-52.6%2024$447.0K-64.9%2023$1.27M-10.7%2022$1.43M+114.3%2021$666.0K+2048.4%2020$31.0K-91.2%2019$353.0K-45.9%2018$653.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share